PPT-Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?

Expert Panelists Program Goals Evaluating CV Risk in New Antidiabetic Therapies FDA Guidance EXAMINE and SAVORTIMI 53 EXAMINE New Analyses SAVORTIMI 53 Saxagliptin in Patients With T2D and History ofat Risk for CV Events. Table2PopulationcharacteristicsAge(mean,SD)59Male(,%)100(47)BMI(mean,SD)28BSA(mean,SD)1.9BestGCS(median,IQR)7(5 Jeff Gomes. Applied . Modelling. and Computation . Group. (AMCG). Severe Accident Subproject Meeting. 14/11/2011. Outline. Multi-Physics Software Suite;. Next-Generation Multiphase Flow Dynamic core (synergy between projects within AMCG);. Emily Lorino. Coordinator for Leadership Development. NASPA-FL Drive-In . October 3, 2014. Corinne Olsen. Student Government Director for Leadership. Overview. History of the Office of Multicultural & Leadership Development. Results Range of movement Mean 1. AACE Prediabetes Consensus Statement: Summary. Untreated individuals with prediabetes are at increased risk for diabetes as well as for micro- and macrovascular complications. Treatment goals are to prevent deterioration in glucose levels and modify other risk factors such as obesity, hypertension, and dyslipidemia . From Creation to Cultural Shift. Erica Werpetinski & Meghan Bernstein. Who we are. Larkin Street Youth Services. San Francisco, CA. “The mission of Larkin Street Youth Services is to create a continuum of services that inspires youth to move beyond the street. We will nurture potential, promote dignity, and support bold steps by all.” . Important Terms. Emerging . infectious disease- . An infectious disease that has newly appeared in a population or that has been known for some time but is rapidly increasing in incidence or geographic range. AACE Prediabetes Consensus Statement: Summary. Untreated individuals with prediabetes are at increased risk for diabetes as well as for micro- and macrovascular complications. Treatment goals are to prevent deterioration in glucose levels and modify other risk factors such as obesity, hypertension, and dyslipidemia . Annual General Meeting. 28. th. November 2013. JPMorgan Global Emerging Markets Income Trust plc . 31. st. July 2012 . – . 31. st. July 2013. Portfolio return . 15.8. %. Index . 5.4%. Return to shareholders 12.1%. Clinical Presentation of Type 2 Diabetes 1 Age ≥45 years Family history of T2D or cardiovascular disease Overweight or obese Sedentary lifestyle Non-Caucasian ancestry Previously identified IGT, IFG, and/or metabolic syndrome Dr. . Urfi. ?. COVID-19. Zika. AIDS . Avian Influenza. Ebola. Marburg . Cholera. Rift Valley Fever. Typhoid. Tuberculosis. Leptospirosis. Malaria . Chikungunya. Dengue, JE. Antimicrobial resistance. UP. What Every Cardiologist in 2019 Needs to Know About. Cardiometabolic Risk Reduction and the Treatment of Diabetes Mellitus”. May 30, 2019. New York City, NY. Keith C. Ferdinand, MD, FACC, FAHA, FASH, FNLA. Zoonoses. . Emerging Zoonoses. . According to the WHO emerging . zoonoses. is "a . zoonosis. that is . newly recognized . or . newly evolved. , or that has occurred previously but shows an increase in incidence or expansion in geographical, host or vector range”. T. he . trial sponsor . compiles . a detailed clinical study report (CSR. ) after each clinical trial. . This report follows . a format laid down by the regulatory . authorities.. The CSR can be hundreds of pages long..